Ceres Global Consulting, a division of The Ceres Group, specializes in the generic pharmaceutical industry focusing on all aspects of the product life cycle including research, formulations, pilot and scale up studies, development, manufacturing, pharmacovigilance, marketing, sales, and distribution of generic prescription drugs.  At every step of the process we bring experience, industry contacts, and attention to detail.

For our partners filing or selling in the U.S. market, we are able to handle all aspects of communication with the U.S. Food and Drug Administration (“FDA”) and ensure a smooth approval process.  We can also bring valuable resources as part of The Ceres Group for paragraph-IV filings where litigation is anticipated.  Our understanding of the FDA’s unique requirements for facilities, molecules, and drug forms, makes us a valuable asset for our global partners.

Our goal is to provide high quality, best-in-class services to our partners to ensure a smooth and valuable product life cycle.

More information about Ceres Global Consulting, including contact information, can be found on our dedicated website at www.ceresglobalconsulting.com.